본문 바로가기
KERD
논문KCI 등재

Telomere Biology in Mood Disorders: An Updated, Comprehensive Review of the Literature

Ather Muneer|Fareed Aslam Minhas
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2019.08|Clinical Psychopharmacology and Neuroscience|제17권 제3호|pp. 343-363|DOI https://doi.org/10.9758/cpn.2019.17.3.343

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

MortalityAgingMood disordersLeukocyte telomere lengthTelomerase activity

초록

Major psychiatric disorders are linked to early mortality and patients afflicted with these ailments demonstrate an increased risk of developing physical diseases that are characteristically seen in the elderly. Psychiatric conditions like major depressive disorder, bipolar disorder and schizophrenia may be associated with accelerated cellular aging, indicated by shortened leukocyte telomere length (LTL), which could underlie this connection. Telomere shortening occurs with repeated cell division and is reflective of a cell’s mitotic history. It is also influenced by cumulative exposure to inflammation and oxidative stress as well as the availability of telomerase, the telomere-lengthening enzyme. Precariously short telomeres can cause cells to undergo senescence, apoptosis or genomic instability; shorter LTL correlates with compromised general health and foretells mortality. Important data specify that LTL may be reduced in principal psychiatric illnesses, possibly in proportion to exposure to the ailment. Telomerase, as measured in peripheral blood monocytes, has been less well characterized in psychiatric illnesses, but a role in mood disorder has been suggested by preclinical and clinical studies. In this manuscript, the most recent studies on LTL and telomerase activity in mood disorders are comprehensively reviewed, potential mediators are discussed, and future directions are suggested. An enhanced comprehension of cellular aging in psychiatric illnesses could lead to their re-conceptualizing as systemic ailments with manifestations both inside and outside the brain. At the same time this paradigm shift could identify new treatment targets, helpful in bringing about lasting cures to innumerable sufferers across the globe.

Abstract

Major psychiatric disorders are linked to early mortality and patients afflicted with these ailments demonstrate an increased risk of developing physical diseases that are characteristically seen in the elderly. Psychiatric conditions like major depressive disorder, bipolar disorder and schizophrenia may be associated with accelerated cellular aging, indicated by shortened leukocyte telomere length (LTL), which could underlie this connection. Telomere shortening occurs with repeated cell division and is reflective of a cell’s mitotic history. It is also influenced by cumulative exposure to inflammation and oxidative stress as well as the availability of telomerase, the telomere-lengthening enzyme. Precariously short telomeres can cause cells to undergo senescence, apoptosis or genomic instability; shorter LTL correlates with compromised general health and foretells mortality. Important data specify that LTL may be reduced in principal psychiatric illnesses, possibly in proportion to exposure to the ailment. Telomerase, as measured in peripheral blood monocytes, has been less well characterized in psychiatric illnesses, but a role in mood disorder has been suggested by preclinical and clinical studies. In this manuscript, the most recent studies on LTL and telomerase activity in mood disorders are comprehensively reviewed, potential mediators are discussed, and future directions are suggested. An enhanced comprehension of cellular aging in psychiatric illnesses could lead to their re-conceptualizing as systemic ailments with manifestations both inside and outside the brain. At the same time this paradigm shift could identify new treatment targets, helpful in bringing about lasting cures to innumerable sufferers across the globe.

참고문헌 (97)

  1. Liu MY, "The emerging roles for telomerase in the central nervous system", Front Mol Neurosci, 11, pp.160~ (2018)
  2. Manoliu A, "The potential impact of biochemical mediators on telomere attrition in major depressive disorder and implications for future study designs : a narrative review", J Affect Disord, 225, pp.630~646 (2018)
  3. Xie X, "Major depressive disorder mediates accelerated aging in rats subjected to chronic mild stress", Behav Brain Res, 329, pp.96~103 (2017)
  4. Maurya PK, "Shorter leukocyte telomere length in patients at ultra high risk for psychosis", Eur Neuropsychopharmacol, 27, pp.538~542 (2017)
  5. Zhu Y, "Telomere and its role in the aging pathways : telomere shortening, cell senescence and mitochondria dysfunction", Biogerontology, 20, pp.1~16 (2019)
  6. Barnes RP, "The impact of oxidative DNA damage and stress on telomere homeostasis", Mech Ageing Dev, 177, pp.37~45 (2019)
  7. Sui B, "Mitochondrial metabolic failure in telomere attrition-provoked aging of bone marrow mesenchymal stem cells", Biogerontology, 17, pp.267~279 (2016)
  8. Bertuch AA, "The molecular genetics of the telomere biology disorders", RNA Biol, 13, pp.696~706 (2016)
  9. Révész D, "Baseline biopsychosocial determinants of telomere length and 6-year attrition rate", Psychoneuroendocrinology, 67, pp.153~162 (2016)
  10. Müezzinler A, "A systematic review of leukocyte telomere length and age in adults", Ageing Res Rev, 12, pp.509~519 (2013)
  11. Schmidt JC, "Human telomerase : biogenesis, trafficking, recruitment, and activation", Genes Dev, 29, pp.1095~1105 (2015)
  12. Bhattacharyya J, "Telomere length as a potential biomarker of coronary artery disease", Indian J Med Res, 145, pp.730~737 (2017)
  13. Epel ES, "The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men", Aging(Albany NY), 1, pp.81~88 (2008)
  14. Nilsson PM, "Telomeres and cardiovascular disease risk : an update 2013", Transl Res, 162, pp.371~380 (2013)
  15. Codd V, "Identification of seven loci affecting mean telomere length and their association with disease", Nat Genet, 45, pp.422~427 (2013)
  16. Zhang J, "Ageing and the telomere connection : an intimate relationship with inflammation", Ageing Res Rev, 25, pp.55~69 (2016)
  17. Liu L, "Linking telomere regulation to stem cell pluripotency", Trends Genet, 33, pp.16~33 (2017)
  18. Cai Z, "Telomere shortening and Alzheimer's disease", Neuromolecular Med, 15, pp.25~48 (2013)
  19. Huang YC, "Leukocyte telomere length in patients with bipolar disorder : an updated meta-analysis and subgroup analysis by mood status", Psychiatry Res, 270, pp.41~49 (2018)
  20. Darrow SM, "The association between psychiatric disorders and telomere length : a meta-analysis involving 14, 827 persons", Psychosom Med, 78, pp.776~787 (2016)
  21. Ten Have M, "Recurrence and chronicity of major depressive disorder and their risk indicators in a population cohort", Acta Psychiatr Scand, 137, pp.503~515 (2018)
  22. Nunes PV, "Low brain-derived neurotrophic factor levels in post-mortem brains of older adults with depression and dementia in a large clinicopathological sample", J Affect Disord, 241, pp.176~181 (2018)
  23. Simon NM, "Telomere shortening and mood disorders : preliminary support for a chronic stress model of accelerated aging", Biol Psychiatry, 60, pp.432~435 (2006)
  24. Verhoeven JE, "Major depressive disorder and accelerated cellular aging : results from a large psychiatric cohort study", Mol Psychiatry, 19, pp.895~901 (2014)
  25. Gotlib IH, "Telomere length and cortisol reactivity in children of depressed mothers", Mol Psychiatry, 20, pp.615~620 (2015)
  26. Shalev I, "Internalizing disorders and leukocyte telomere erosion : a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder", Mol Psychiatry, 19, pp.1163~1170 (2014)
  27. Jodczyk S, "No association between mean telomere length and life stress observed in a 30 year birth cohort", PLoS One, 9, pp.e97102~ (2014)
  28. Hoen PW, "Depression and leukocyte telomere length in patients with coronary heart disease : data from the heart and soul study", Psychosom Med, 73, pp.541~547 (2011)
  29. Hoen PW, "Association between anxiety but not depressive disorders and leukocyte telomere length after 2 years of follow-up in a population-based sample", Psychol Med, 43, pp.689~697 (2013)
  30. Schaakxs R, "Leukocyte telomere length and late-life depression", Am J Geriatr Psychiatry, 23, pp.423~432 (2015)
  31. Kananen L, "Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls", PLoS One, 5, pp.e10826~ (2010)
  32. Needham BL, "Depression, anxiety and telomere length in young adults : evidence from the National Health and Nutrition Examination Survey", Mol Psychiatry, 20, pp.520~528 (2015)
  33. Teyssier JR, "Up-regulation of leucocytes genes implicated in telomere dysfunction and cellular senescence correlates with depression and anxiety severity scores", PLoS One, 7, pp.e49677~ (2012)
  34. Wolkowitz OM, "Leukocyte telomere length in major depression : correlations with chronicity, inflammation and oxidative stress--preliminary findings", PLoS One, 6, pp.e17837~ (2011)
  35. Lindqvist D, "Psychiatric disorders and leukocyte telomere length : underlying mechanisms linking mental illness with cellular aging", Neurosci Biobehav Rev, 55, pp.333~364 (2015)
  36. Russo P, "Shorter telomere length in schizophrenia : evidence from a real-world population and meta-analysis of most recent literature", Schizophr Res, 202, pp.37~45 (2018)
  37. Elvsåshagen T, "The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder", J Affect Disord, 135, pp.43~50 (2011)
  38. Rizzo LB, "Immunosenescence is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder", Bipolar Disord, 15, pp.832~838 (2013)
  39. Martinsson L, "Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres", Transl Psychiatry, 3, pp.e261~ (2013)
  40. Lima IM, "Analysis of telomere attrition in bipolar disorder", J Affect Disord, 172, pp.43~47 (2015)
  41. Barbé-Tuana FM, "Shortened telomere length in bipolar disorder : a comparison of the early and late stages of disease", Braz J Psychiatry, 38, pp.281~286 (2016)
  42. Verhoeven JE, "Depressive and anxiety disorders showing robust, but non-dynamic, 6-year longitudinal association with short leukocyte telomere length", Am J Psychiatry, 173, pp.617~624 (2016)
  43. Hartmann N, "Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease", Depress Anxiety, 27, pp.1111~1116 (2010)
  44. Solana C, "Early senescence and leukocyte telomere shortening in schizophrenia : a role for cytomegalovirus infection", Brain Sci, 8, pp.188~ (2018)
  45. Nguyen TT, "Systemic biomarkers of accelerated aging in schizophrenia : a critical review and future directions", Schizophr Bull, 44, pp.398~408 (2018)
  46. Osler M, "Stressful life events and leucocyte telomere length : do lifestyle factors, somatic and mental health, or low grade inflammation mediate this relationship? Results from a cohort of Danish men born in 1953", Brain Behav Immun, 58, pp.248~253 (2016)
  47. Provenzi L, "Telomere length in preterm infants: a promising biomarker of early adversity and care in the neonatal intensive care unit", Front Endocrinol (Lausanne), 8, pp.295~ (2017)
  48. Wilson SJ, "Loneliness and telomere length : immune and parasympathetic function in associations with accelerated aging", Ann Behav Med, 53, pp.541~550 (2019)
  49. Wolkowitz OM, "Of sound mind and body : depression, disease, and accelerated aging", Dialogues Clin Neurosci, 13, pp.25~39 (2011)
  50. Wolkowitz OM, "Depression gets old fast : do stress and depression accelerate cell aging", Depress Anxiety, 27, pp.327~338 (2010)
  51. Tolahunase M, "Impact of yoga and meditation on cellular aging in apparently healthy individuals : a prospective, open-label single-arm exploratory study", Oxid Med Cell Longev, 2017, pp.7928981~ (2017)
  52. Révész D, "Dysregulated physiological stress systems and accelerated cellular aging", Neurobiol Aging, 35, pp.1422~1430 (2014)
  53. Aulinas A, "Telomere length analysis in Cushing's syndrome", Eur J Endocrinol, 171, pp.21~29 (2014)
  54. Tomiyama AJ, "Does cellular aging relate to patterns of allostasis? An examination of basal and stress reactive HPA axis activity and telomere length", Physiol Behav, 106, pp.40~45 (2012)
  55. Drury SS, "Growing up or growing old? Cellular aging linked with testosterone reactivity to stress in youth", Am J Med Sci, 348, pp.92~100 (2014)
  56. Vasunilashorn S, "Stress responsive biochemical anabolic", catabolic ratio and telomere length in older adults, 2014, pp.60, 174~184
  57. Savolainen K, "History of mental disorders and leukocyte telomere length in late adulthood : the Helsinki Birth Cohort Study(HBCS)", J Psychiatr Res, 46, pp.1346~1353 (2012)
  58. Toriumi K, "JSNP Excellent Presentation Award for CINP2014", Jpn J Psychopharmacol, 35, pp.61~62 (2015)[DOI]
  59. Boccardi V, "Telomerase activation : a potential key modulator for human healthspan and longevity", Ageing Res Rev, 15, pp.1~5 (2014)
  60. Choudhary B, "Telomere and telomerase in stem cells: relevance in ageing and disease", Front Biosci (Schol Ed), 4, pp.16~30 (2012)
  61. Ozturk MB, "Current insights to regulation and role of telomerase in human diseases", Antioxidants(Basel), 6, pp.17~ (2017)
  62. Zalli A, "Shorter telomeres with high telomerase activity are associated with raised allostatic load and impoverished psychosocial resources", Proc Natl Acad Sci U S A, 111, pp.4519~4524 (2014)
  63. Vaváková M, "Markers of oxidative stress and neuroprogression in depression disorder", Oxid Med Cell Longev, 2015, pp.898393~ (2015)
  64. Jaskelioff M, "Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice", Nature, 469, pp.102~106 (2011)
  65. Xie X, "Desipramine rescues age-related phenotypes in depression-like rats induced by chronic mild stress", Life Sci, 188, pp.96~100 (2017)
  66. Zhou QG, "Hippocampal TERT regulates spatial memory formation through modulation of neural development", Stem Cell Reports, 9, pp.543~556 (2017)
  67. Epel ES, "Accelerated telomere shortening in response to life stress", Proc Natl Acad Sci U S A, 101, pp.17312~17315 (2004)
  68. Epel ES, "Dynamics of telomerase activity in response to acute psychological stress", Brain Behav Immun, 24, pp.531~539 (2010)
  69. Damjanovic AK, "Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients", J Immunol, 179, pp.4249~4254 (2007)
  70. Wolkowitz OM, "Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response", Mol Psychiatry, 17, pp.164~172 (2012)
  71. Porton B, "Telomerase levels in schizophrenia : a preliminary study", Schizophr Res, 106, pp.242~247 (2008)
  72. Wang M, "The NVL gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population", Prog Neuropsychopharmacol Biol Psychiatry, 62, pp.7~13 (2015)
  73. Wei YB, "hTERT genetic variation in depression", J Affect Disord, 189, pp.62~69 (2016)
  74. Tolahunase MR, "Yoga-and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder : a randomized controlled trial", Restor Neurol Neurosci, 36, pp.423~442 (2018)
  75. Wei YB, "Telomerase dysregulation in the hippocampus of a rat model of depression: normalization by lithium", Int J Neuropsychopharmacol, 18, pp.pyv002~ (2015)
  76. Köse Çinar R, "Telomere length and hTERT in mania and subsequent remission", Braz J Psychiatry, 40, pp.19~25 (2018)
  77. Squassina A, "Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients", Eur Neuropsychopharmacol, 26, pp.1241~1247 (2016)
  78. Daniali L, "Telomeres shorten at equivalent rates in somatic tissues of adults", Nat Commun, 4, pp.1597~ (2013)
  79. Dlouha D, "Comparison of the relative telomere length measured in leukocytes and eleven different human tissues", Physiol Res, 63(Suppl 3), pp.S343~S350 (2014)
  80. Teyssier JR, "Telomeres in the brain cortex of depressive patients", Encephale, 36, pp.491~494 (2010)
  81. Zhang D, "Cerebellar telomere length and psychiatric disorders", Behav Genet, 40, pp.250~254 (2010)
  82. Szebeni A, "Shortened telomere length in white matter oligodendrocytes in major depression : potential role of oxidative stress", Int J Neuropsychopharmacol, 17, pp.1579~1589 (2014)
  83. Wikgren M, "Shorter telomere length is linked to brain atrophy and white matter hyperintensities", Age Ageing, 43, pp.212~217 (2014)
  84. Jacobs EG, "Relationship between leukocyte telomere length, telomerase activity, and hippocampal volume in early aging", JAMA Neurol, 71, pp.921~923 (2014)
  85. King KS, "Effect of leukocyte telomere length on total and regional brain volumes in a large population-based cohort", JAMA Neurol, 71, pp.1247~1254 (2014)
  86. Wolkowitz OM, "PBMC telomerase activity, but not leukocyte telomere length, correlates with hippocampal volume in major depression", Psychiatry Res, 232, pp.58~64 (2015)
  87. Deng W, "Telomerase activity and its association with psychological stress, mental disorders, lifestyle factors and interventions : a systematic review", Psychoneuroendocrinology, 64, pp.150~163 (2016)
  88. Schutte NS, "A meta-analytic review of the effects of mindfulness meditation on telomerase activity", Psychoneuroendocrinology, 42, pp.45~48 (2014)
  89. Jacobs TL, "Intensive meditation training, immune cell telomerase activity, and psychological mediators", Psychoneuroendocrinology, 36, pp.664~681 (2011)
  90. Lengacher CA, "Influence of mindfulness-based stress reduction(MBSR)on telomerase activity in women with breast cancer(BC)", Biol Res Nurs, 16, pp.438~447 (2014)
  91. Ornish D, "Increased telomerase activity and comprehensive lifestyle changes : a pilot study", Lancet Oncol, 9, pp.1048~1057 (2008)
  92. Ornish D, "Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer : 5-year follow-up of a descriptive pilot study", Lancet Oncol, 14, pp.1112~1120 (2013)
  93. Arsenis NC, "Physical activity and telomere length : impact of aging and potential mechanisms of action", Oncotarget, 8, pp.45008~45019 (2017)
  94. Puterman E, "Multisystem resiliency moderates the major depression-telomere length association : findings from the Heart and Soul Study", Brain Behav Immun, 33, pp.65~73 (2013)
  95. Puterman E, "The power of exercise : buffering the effect of chronic stress on telomere length", PLoS One, 5, pp.e10837~ (2010)
  96. Puterman E, "Determinants of telomere attrition over 1 year in healthy older women : stress and health behaviors matter", Mol Psychiatry, 20, pp.529~535 (2015)
  97. Biegler KA, "Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention", Cancer Prev Res(Phila), 5, pp.1173~1182 (2012)

관련 논문AI추천

Significant Shortening of Leukocyte Telomere Length in Korean Patients with Bipolar Disorder 1김순애, Eun-Jeong Joo, Mira Park, Yong Min Ahn대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제3호Longer Telomere Length of T lymphocytes in Patients with Early and Chronic Psychosis정영철, Subramaniam Mohana Devi, Thong Ba Nguyen, Vishwanath Vasudev Prabhu, Yin Cui대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2017 · 제15권 제2호Is Telomere Length Shortening a Risk Factor for Neurodegenerative Disorders?Koh Seong-Ho, Yu Hyun-Jung대한치매학회 · Dementia and Neurocognitive Disorders(대한치매학회지)2022 · 제21권 제3호Bipolar Disorder: Role of Inflammation and the Development of Disease BiomarkersAther Muneer대한신경정신의학회 · PSYCHIATRY INVESTIGATION2016 · 제13권 제1호8-Hydroxy-2’-Deoxyguanosine and Reactive Oxygen Species as Biomarkers of Oxidative Stress in Mental Illnesses: A Meta-AnalysisPek Yee Tang, Shiau Foon Tee, Xue Xin Goh대한신경정신의학회 · PSYCHIATRY INVESTIGATION2021 · 제18권 제7호The Staging of Major Mood Disorders: Clinical and Neurobiological CorrelatesAther Muneer, Rana Mazommil대한신경정신의학회 · PSYCHIATRY INVESTIGATION2018 · 제15권 제8호

이 간행물의 다른 논문 (15건)

Serum Prolactin and Bone Mineral Density in Schizophrenia: A Systematic ReviewJohn Lally, Brendon Stubbs, Fiona Gaughran, Kieran C. Murphy, Abdullah Bin Sahlpp. 333-342Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1Changsu Han, Chi-Un Pae, Soo-Jung Lee, Ashwin A Patkar, Concetta Crisafulli, Tae-Youn Jun, Marco Calabrò, Prakash S Masand, Laura Mandelli, Sheng Min Wang, Alessandro Serrettipp. 364-368Validation of the Korean Version of the Depression in Old Age Scale and Comparison with Other Depression Screening Questionnaires Used in Elderly Patients in Medical SettingsBeomwoo Nam, Ji Sun Kim, Jeong Seok Seo, Won-Myong Bahk, Young Sup Woo, Moon Doo Kim, Bo-Hyun Yoon, In Hee Shim, Sae-Heon Jang, Young Joon Kwon, Young-Eun Jung, Hyung-Mo Sungpp. 369-376Frontal Alpha Asymmetry Correlates with Suicidal Behavior in Major Depressive DisorderHyunjin Jeon, Yeonsoo Park, Wookyoung Jung, Sungkean Kim, 이승환pp. 377-387Differential Effects of Pentoxifylline on Learning and Memory Impairment Induced by Hypoxic-ischemic Brain Injury in RatsSoner Bitiktaş, Cem Süer, Hülya Halis, Tamer Güneş, Şehrazat Kavraal, Burak Tan, Osman Baştuğpp. 388-399
원문 보기